State of Wisconsin Investment Board
PTLA

State of Wisconsin Investment Board’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

State of Wisconsin Investment Board’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-124,200
Closed -$2.23M – 2027
2020
Q2 		$2.23M Sell
124,200
-165,136
-57% -$2.3M 0.01% 1103
2020
Q1 		$2.06M Buy
289,336
+32,200
+13% +$402K 0.01% 1060
2019
Q4 		$6.14M Buy
257,136
+94,257
+58% +$2.6M 0.02% 874
2019
Q3 		$4.37M Buy
162,879
+32,119
+25% +$902K 0.01% 847
2019
Q2 		$3.55M Buy
130,760
+18,850
+17% +$591K 0.01% 902
2019
Q1 		$3.88M Buy
111,910
+21,300
+24% +$615K 0.01% 870
2018
Q4 		$1.77M Buy
90,610
+1,910
+2% +$39.3K 0.01% 992
2018
Q3 		$2.36M Buy
88,700
+22,300
+34% +$728K 0.01% 1011
2018
Q2 		$2.51M Buy
66,400
+15,733
+31% +$602K 0.01% 962
2018
Q1 		$1.66M Hold
50,667
– – ﹤0.01% 1000
2017
Q4 		$2.47M Hold
50,667
– – 0.01% 951
2017
Q3 		$2.74M Buy
50,667
+12,667
+33% +$744K 0.01% 937
2017
Q2 		$2.13M Buy
+38,000
New +$1.52M 0.01% 938

State of Wisconsin Investment Board's PTLA Position: Q3 2020 in Review

State of Wisconsin Investment Board sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 124,200 shares — an estimated $2.23M sold.

State of Wisconsin Investment Board first reported a position in PTLA in Q2 2017 and held it in 13 quarters. The position peaked at $6.14M in Q4 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • State of Wisconsin Investment Board reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 124,200 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2.23M.
  • State of Wisconsin Investment Board first reported a position in Portola Pharmaceuticals, Inc. in Q2 2017 and held it in 13 quarters.
  • State of Wisconsin Investment Board's Portola Pharmaceuticals, Inc. position peaked at $6.14M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2020, filed 16 Nov 2020.